Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing

Abstract Background Multi–gene panel sequencing using next-generation sequencing (NGS) methods is a key tool for genomic medicine. However, with an estimated 140 000 genomic tests available, current system inefficiencies result in high genetic-testing costs. Reduced testing costs are needed to expan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical chemistry (Baltimore, Md.) Md.), 2021-08, Vol.67 (8), p.1122-1132
Hauptverfasser: Katragadda, Shanmukh, Hall, Taryn O, Bettadapura, Radhakrishna, Dalton, Joline C, Ganapathy, Aparna, Ghana, Pallavi, Hariharan, Ramesh, Janakiraman, Anand, Kotha, Kumar B V S S P, Manjunath, Ashwini, Mannan, Ashraf U, MS, Niveditha, Saraf, Shradha, Tzeng, Kathy T H, Veeramachaneni, Vamsi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!